Biofidelity
Latest round
- Series A
Last raised
- Dec 2021
Total raised
- $36M
Investors
- 5
About Biofidelity
Based in Cambridge, UK, and founded in 2019 by co-founders Barnaby Balmforth (CEO) and Cameron Frayling, Biofidelity Ltd. operates as a provider of diagnostic assays for disease detection and monitoring to assess and implement therapies that enable the multiplexed detection of genetic mutations without performing DNA sequencing. In February 2024, Biofidelity Ltd. The company provides a wide range of genomic testing services, such as ASPYRE technology for actionable biomarker detection, ASPYRE-Lung for lung cancer biomarker analysis, and ENSPYRE for genomic precision testing.
Who invested in Biofidelity
5 investors across 3 rounds
See all investors in Biofidelity
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Biofidelity
Who invested in Biofidelity?
Biofidelity has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Biofidelity raised?
Biofidelity has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Biofidelity last raise money?
Biofidelity's most recent round on record is a Series A, in Dec 2021.
What does Biofidelity do?
Based in Cambridge, UK, and founded in 2019 by co-founders Barnaby Balmforth (CEO) and Cameron Frayling, Biofidelity Ltd.
Where is Biofidelity headquartered?
Biofidelity is headquartered in Cambridge, UK.
Which VCs invest in companies like Biofidelity?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Biofidelity's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Biofidelity? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.